Systemic Lupus Erythematosus (SLE) Clinical Trials

Find Systemic Lupus Erythematosus (SLE) Clinical Trials Near You

A Phase 3, Randomized, Double-Blind,Placebo-Controlled Parallel Study to Evaluate the Efficacy and Safety of Enpatoran in Participants With Active Cutaneous Manifestations of Lupus Erythematosus With or Without Systemic Disease Receiving Standard of Care (ELOWEN-1)

Status: Recruiting
Location: See all (60) locations...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 3
SUMMARY

The purpose of this global, multicenter, Phase 3 study is to evaluate the efficacy and safety of enpatoran over 24 weeks in participants with active cutaneous manifestations of lupus erythematosus with or without systemic disease. Study details include: Study Duration: Up to 35 weeks. Treatment Duration: 24 weeks. Visit Frequency: every 4 weeks, with the exception of the Week 2 televisit. Study Intervention Name: Enpatoran, Placebo. Intervention Form: Film-coated tablet.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 75
Healthy Volunteers: f
View:

• Vaccinations are up to date according to local guidelines/recommendations. Recombinant zoster vaccination is encouraged but not mandatory.

• Participants with diagnosis of Discoid Lupus Erythematosus (DLE) and/or Subacute Cutaneous Lupus Erythematosus (SCLE) documented in medical history, with or without Systemic Lupus Erythematosus (SLE).

• Participants with active Acute Cutaneous Lupus Erythematosus (ACLE) as sole cutaneous manifestations is allowed in the presence of SLE and should be present for at least 6 weeks prior to the Screening visit.

• Participants with diagnosis of SLE fulfilling the European Alliance of Associations for Rheumatology (EULAR)/American College of Rheumatology (ACR) 2019 classification criteria, must have active DLE and/or SCLE and/or ACLE.

⁃ For participants with SLE:

• Participants with diagnosis of SLE and fulfill EULAR/ACR 2019 classification criteria.

• Participants with disease duration (cutaneous disease and, where applicable, SLE) of \>= 6 months from time of diagnosis to Screening.

• Participants with CLASI-A score \>= 8 at Screening and Day 1 visits.

• Other protocol-defined inclusion criteria may apply.

Locations
United States
California
Dermatology Research Associates - 300204025
RECRUITING
Los Angeles
Cohen Medical Centers
RECRUITING
Thousand Oaks
Florida
GNP Research at Mark Jaffe, MD
RECRUITING
Cooper City
Advance Medical Research Center
RECRUITING
Miami
Diverse Clinical Research LLC
RECRUITING
Miami
D&H National Research Centers, Inc.
RECRUITING
Tamarac
Clinical Research of West Florida, Inc.
RECRUITING
Tampa
Georgia
Emory University School of Medicine
RECRUITING
Atlanta
Michigan
Revival Research Institute, LLC
RECRUITING
Troy
Texas
Allen Arthritis
RECRUITING
Allen
Arthritis and Rheumatology Research Institute PLLC
RECRUITING
Allen
Arthritis Care of Texas
RECRUITING
Corpus Christi
Other Locations
Australia
Rheumatology Research Unit Sunshine Coast
RECRUITING
Maroochydore
Brazil
Hospital de Câncer de Barretos - Fundação Pio XII - Hospital de Amor de Barretos
RECRUITING
Barretos
Freire Pesquisa Clinica
RECRUITING
Belo Horizonte
IPC MT Instituto de Pesquisas Clinicas do Mato Grosso
RECRUITING
Cuiabã¡
HUWC - UFC - Hospital Universitário Walter Cantídio - Universidade Federal do Ceará
RECRUITING
Fortaleza
Clínica SER da Bahia
RECRUITING
Salvador
Bulgaria
DCC V Plovdiv Sv. Archbishop Luka EOOD
RECRUITING
Plovdiv
Ambulatory for Specialized Medical Help - skin and venereal diseases
RECRUITING
Sofia
France
Hopital Tenon - service dermatologie et centre d'allergie
RECRUITING
Paris
CHU Saint Etienne - Hôpital Nord - service de medecine interne
RECRUITING
Saint-étienne-de-montluc
Germany
Charité - Campus Charité Mitte - Klinik fuer Dermatol., Venerol., Allergologie
RECRUITING
Berlin
Elbekliniken Buxtehude GmbH - Dermatologie
RECRUITING
Buxtehude
Universitaetsklinikum Carl Gustav Carus TU Dresden
RECRUITING
Dresden
Israel
Chaim Sheba Medical Center - pt
RECRUITING
Ramat Gan
Italy
Azienda USL Toscana Centro - Ospedale Piero Palagi
RECRUITING
Florence
Università Campus Bio-Medico di Roma - UOC Reumatologia
RECRUITING
Roma
Japan
NHO Asahikawa Medical Center - Dept of Gastroenterology
RECRUITING
Asahikawa-shi
Institute of Science Tokyo Hospital - Dept of Dermatology
RECRUITING
Bunkyo-ku
NHO Chibahigashi National Hospital - Dept of Allergy/Rheumatology
RECRUITING
Chiba
St. Luke's International Hospital - Dept of Immunology/Allergy
RECRUITING
Chūōku
Fukushima Medical University Hospital - Dept of Rheumatology/Immunology
RECRUITING
Fukushima
Kanazawa University Hospital - Dept of Rheumatology/Immunology
RECRUITING
Kanazawa
Hospital of the University of Occupational and Environmental Health - Dept of Dermatology
RECRUITING
Kitakyushu-shi
Kobe University Hospital - Dept of Immunology/Rheumatology
RECRUITING
Kobe
JCHO Chukyo Hospital - Dept of Dermatology
RECRUITING
Nagoya
Okayama University Hospital - Dept of Rheumatology/Immunology
RECRUITING
Okayama
Sapporo City General Hospital - Dept of Rheumatology/Immunology
RECRUITING
Sapporo
Tohoku Medical and Pharmaceutical University Hospital - Dept of Hematology/Rheumatology
RECRUITING
Sendai
The University of Osaka Hospital - Dept of Dermatology
RECRUITING
Suita-shi
Yokohama City University Hospital - Dept of Dermatology
RECRUITING
Yokohama
Poland
Centrum Badan Klinicznych JCI
RECRUITING
Krakow
ETG Lublin - ETG NETWORK Sp. z o.o.
RECRUITING
Lublin
Centrum Badawcze Panaceum Agnieszka Brzezicka, Magdalena Lenkiewicz Sp. z o.o.
RECRUITING
Malbork
SOMED CR
RECRUITING
Rzeszów
Uniwersytecki Szpital Kliniczny im Fryderyka Chopina w Rzeszowie - Klinika Dermatologii i Dermatologii Onkologicznej
RECRUITING
Rzeszów
REUMA CENTRUM Specjalistyczna Praktyka Lekarska Dr n. med. Jakub Trefler
RECRUITING
Warsaw
Velocity Zamosc
RECRUITING
Zamość
Republic of Korea
Korea University Ansan Hospital - 300133335
RECRUITING
Ansan-si
Gachon University Gil Medical Center
RECRUITING
Incheon
Seoul National University Bundang Hospital
RECRUITING
Seongnam-si
Romania
Futuremeds S R L.
RECRUITING
Brasov
Slovakia
Artromac n.o. - Reumatologicka ambulancia
RECRUITING
Košice
Spain
Complejo Hospitalario Universitario de Santiago - Dermatology Unit
RECRUITING
Santiago De Compostela
Hospital General Universitario de Valencia - Rheumatology
RECRUITING
Valencia
Switzerland
Universitaetsspital Basel - Klinik fuer Dermatologie
RECRUITING
Basel
Kantonsspital St. Gallen - Klinik f. Dermatologie, Venerologie u Allergologie
RECRUITING
Sankt Gallen
Taiwan
China Medical University Hospital
RECRUITING
Taichung
Chi Mei Medical Center - 300192662
RECRUITING
Tainan
Contact Information
Primary
Communication Center
service@emdgroup.com
+49 6151 72 5200
Time Frame
Start Date: 2026-03-10
Estimated Completion Date: 2029-05-24
Participants
Target number of participants: 202
Treatments
Experimental: Enpatoran
Placebo_comparator: Placebo
Sponsors
Collaborators: Merck KGaA, Darmstadt, Germany
Leads: EMD Serono Research & Development Institute, Inc.

This content was sourced from clinicaltrials.gov

Similar Clinical Trials